Literature DB >> 9607042

Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model.

R Ulrich1, A Lundkvist, H Meisel, D Koletzki, K B Sjölander, H R Gelderblom, G Borisova, P Schnitzler, G Darai, D H Krüger.   

Abstract

Hantaviruses are rodent-born agents which are pathogenic in humans causing haemorrhagic fever with renal syndrome or hantavirus pulmonary syndrome. To induce a protective immunity against a European hantavirus (Puumala) we constructed chimaeric hepatitis B virus (HBV) core particles carrying defined fragments of the Puumala virus nucleocapsid protein. After immunisation of bank voles, the natural host of Puumala virus, with core particles possessing an insertion of the N-terminal part of Puumala virus nucleocapsid protein, four of five animals were protected against subsequent virus challenge. The results show that the major protective region of the nucleocapsid protein is located between amino acids 1 and 45 and that chimaeric HBV core-like particles are useful carriers of foreign protective epitopes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607042     DOI: 10.1016/s0264-410x(97)00172-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice.

Authors:  Dominic Wichmann; Hermann-Josef Gröne; Michael Frese; Jovan Pavlovic; Bärbel Anheier; Otto Haller; Hans-Dieter Klenk; Heinz Feldmann
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.

Authors:  Katleen Broos; Michiel E Janssens; Ine De Goeyse; Peter Vanlandschoot; Geert Leroux-Roels; Dirk Geysen; Yves Guisez
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

Review 3.  The nucleocapsid protein of hantaviruses: much more than a genome-wrapping protein.

Authors:  Monika Reuter; Detlev H Krüger
Journal:  Virus Genes       Date:  2017-11-20       Impact factor: 2.332

4.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

5.  Lethal disease in infant and juvenile Syrian hamsters experimentally infected with Imjin virus, a newfound crocidurine shrew-borne hantavirus.

Authors:  Se Hun Gu; Young-Sik Kim; Luck Ju Baek; Takeshi Kurata; Richard Yanagihara; Jin-Won Song
Journal:  Infect Genet Evol       Date:  2015-09-12       Impact factor: 3.342

Review 6.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

Review 7.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

8.  Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.

Authors:  David Safronetz; Nagendra R Hegde; Hideki Ebihara; Michael Denton; Gary P Kobinger; Stephen St Jeor; Heinz Feldmann; David C Johnson
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Authors:  Cristina de Carvalho Nicacio; Marcelo Gonzalez Della Valle; Paula Padula; Ewa Björling; Alexander Plyusnin; Ake Lundkvist
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Expression of immunogenic Puumala virus nucleocapsid protein in transgenic tobacco and potato plants.

Authors:  R Kehm; N J Jakob; T M Welzel; E Tobiasch; O Viczian; S Jock; K Geider; S Süle; G Darai
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.